Phase 2 Trial of Chidamide-Lenalidomide-Dexamethasone(CRD) Regimen in R/R MM

Clinical trial NCT03605056 · UNKNOWN

Trial details

NCT number: NCT03605056
Sponsor: Peng Liu
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Multiple Myeloma

Start date: 2018-07-31
Primary completion: 2020-07-31
Enrollment: 25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.